BCL2L11 and ovarian cancer: Similar to our findings in the PDX models, BIM protein levels correlated significantly with drug sensitivity (GNE-493 and ABT-737 IC50) in the ovarian cancer cell lines (Pearson r = 0.7, p = 0.004; Fig. 5g).